| scholarly article | Q13442814 |
| P2093 | author name string | Jeffrey W Pollard | |
| Elaine Y Lin | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macrophage | Q184204 |
| P304 | page(s) | 5064-5066 | |
| P577 | publication date | 2007-06-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Tumor-associated macrophages press the angiogenic switch in breast cancer. | |
| P478 | volume | 67 |
| Q27334748 | 3-D individual cell based computational modeling of tumor cell-macrophage paracrine signaling mediated by EGF and CSF-1 gradients |
| Q42344612 | A Comparative Approach of Tumor-Associated Inflammation in Mammary Cancer between Humans and Dogs |
| Q24615787 | A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss |
| Q27345215 | A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth |
| Q36103026 | A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma |
| Q33802916 | A two-way communication between microglial cells and angiogenic sprouts regulates angiogenesis in aortic ring cultures |
| Q35810840 | Active roles of tumor stroma in breast cancer metastasis |
| Q33900352 | An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis. |
| Q38034321 | Angiogenesis in neurological disorders: a review |
| Q34613492 | Anti-tumour activity of bisphosphonates in preclinical models of breast cancer. |
| Q36101999 | Antiangiogenic therapy for glioma |
| Q38557650 | Applying nanomedicine in maladaptive inflammation and angiogenesis |
| Q49704531 | Association between inflammation and cancer stem cell phenotype in breast cancer |
| Q35653176 | Autocrine CSF-1 and CSF-1 receptor coexpression promotes renal cell carcinoma growth |
| Q36806793 | Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages |
| Q35076287 | Bevacizumab in the treatment of patients with advanced breast cancer: where have we landed? |
| Q38121858 | Biochemical and molecular mechanisms for the association between obesity, chronic inflammation, and breast cancer |
| Q38119453 | Biological and molecular aspects of lymph node metastasis in gastro-intestinal cancer |
| Q36629553 | Bladder cancer cells re-educate TAMs through lactate shuttling in the microfluidic cancer microenvironment |
| Q37576019 | Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor |
| Q37351536 | Breast cancer by proxy: can the microenvironment be both the cause and consequence? |
| Q36099434 | Breast cancer: origins and evolution |
| Q34759911 | Breast tumor microenvironment: proteomics highlights the treatments targeting secretome |
| Q39064583 | Breast tumor stroma: A driving force in the development of resistance to therapies |
| Q33827026 | C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment |
| Q33600422 | CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women |
| Q34995099 | CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages |
| Q51028394 | CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer. |
| Q37496849 | Cancer invasion and metastasis: interacting ecosystems. |
| Q37336637 | Carcinoembryonic antigen-related cell adhesion molecule 1 negatively regulates granulocyte colony-stimulating factor production by breast tumor-associated macrophages that mediate tumor angiogenesis |
| Q33844782 | Changes in immunocompetent cells after interstitial laser thermotherapy of breast cancer |
| Q37330625 | Chapter 15. Methods to study myeloid cell roles in angiogenesis |
| Q34248596 | Chemokine receptor CX3CR1 contributes to macrophage survival in tumor metastasis |
| Q60931267 | Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization |
| Q58792097 | Circulating monocytes from prostate cancer patients promote invasion and motility of epithelial cells |
| Q43535475 | Clinical significance of folate receptor β-expressing tumor-associated macrophages in pancreatic cancer |
| Q48049656 | Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy. |
| Q37318863 | Colony-stimulating factor-1 transfection of myoblasts improves the repair of failing myocardium following autologous myoblast transplantation. |
| Q37777391 | Current and emerging concepts in tumour metastasis |
| Q35124602 | Cytokine production and inflammation drive autophagy in the tumor microenvironment: role of stromal caveolin-1 as a key regulator |
| Q90643299 | Differential impact of classical and non-canonical NF-κB pathway-related gene expression on the survival of breast cancer patients |
| Q64975240 | Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer. |
| Q37694632 | Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma |
| Q35169173 | Early cardiac morphogenesis defects caused by loss of embryonic macrophage function in Xenopus |
| Q33966203 | Eicosanoids and cancer |
| Q46059819 | Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer |
| Q37694918 | Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors |
| Q37786019 | Environmental control of invasiveness and metastatic dissemination of tumor cells: the role of tumor cell-host cell interactions. |
| Q38838643 | Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors |
| Q33703690 | Epithelial-stromal interaction 1 (EPSTI1) substitutes for peritumoral fibroblasts in the tumor microenvironment |
| Q34333453 | Exploring molecular links between lymph node invasion and cancer prognosis in human breast cancer. |
| Q24653754 | Exploring the full spectrum of macrophage activation |
| Q37228477 | Expression of endoglin (CD105) in cervical cancer |
| Q40994644 | Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1. |
| Q81827310 | Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer |
| Q92354511 | G protein-coupled receptor kinase 2 regulating β2-adrenergic receptor signaling in M2-polarized macrophages contributes to hepatocellular carcinoma progression |
| Q35584172 | High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resection |
| Q37150829 | High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors |
| Q34399444 | Histone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies |
| Q36645808 | Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents |
| Q37287162 | How tumours escape mass destruction |
| Q35936770 | Human breast cancer cells educate macrophages toward the M2 activation status |
| Q83419639 | Hypoxia, tumour-associated macrophages, microvessel density, VEGF and matrix metalloproteinases in human gastric cancer: interaction and impact on survival |
| Q35705992 | Hypoxia-inducible factors in cancer stem cells and inflammation |
| Q38845523 | IKKbeta/NF-kappaB and the miscreant macrophage |
| Q26991724 | Immune cell promotion of metastasis |
| Q36125878 | Immune response to cancer therapy: mounting an effective antitumor response and mechanisms of resistance |
| Q36106053 | Immunity, inflammation, and cancer: an eternal fight between good and evil |
| Q36287070 | Impact of p16 status on pro- and anti-angiogenesis factors in head and neck cancers |
| Q36191455 | Improving selective targeting to macrophage subpopulations through modifying liposomes with arginine based materials |
| Q90371942 | In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment |
| Q36663831 | Increased Expression of CSF-1 Associates With Poor Prognosis of Patients With Gastric Cancer Undergoing Gastrectomy |
| Q39816984 | Infiltrating CD11b+CD11c+ cells have the potential to mediate inducible nitric oxide synthase-dependent cell death in mammary carcinomas of HER-2/neu transgenic mice |
| Q38162168 | Inflammatory and microenvironmental factors involved in breast cancer progression |
| Q34984217 | Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition |
| Q35779345 | Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling |
| Q38501776 | Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation |
| Q37170752 | Integrins in angiogenesis and lymphangiogenesis |
| Q37382352 | Interferon regulatory factor-8 modulates the development of tumour-induced CD11b+Gr-1+ myeloid cells. |
| Q38878851 | JAK-STAT signaling in cancer: From cytokines to non-coding genome. |
| Q28396291 | Knockout of the tumor suppressor gene Gprc5a in mice leads to NF-kappaB activation in airway epithelium and promotes lung inflammation and tumorigenesis |
| Q29618033 | Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy |
| Q34578021 | Leukocytes in mammary development and cancer |
| Q37070294 | Longitudinal study of tumor-associated macrophages during tumor expansion using MRI. |
| Q33874288 | Loss of fibroblast HIF-1α accelerates tumorigenesis. |
| Q42182045 | MMP1, MMP9, and COX2 expressions in promonocytes are induced by breast cancer cells and correlate with collagen degradation, transformation-like morphological changes in MCF-10A acini, and tumor aggressiveness. |
| Q34115929 | Macrophage Infiltration in Tumor Stroma is Related to Tumor Cell Expression of CD163 in Colorectal Cancer. |
| Q90699538 | Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk |
| Q37359619 | Macrophage colony-stimulating factor expressed in non-cancer tissues provides predictive powers for recurrence in hepatocellular carcinoma |
| Q29615847 | Macrophage diversity enhances tumor progression and metastasis |
| Q38893448 | Macrophage form, function, and phenotype in mycobacterial infection: lessons from tuberculosis and other diseases |
| Q37990243 | Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine |
| Q38039501 | Macrophages and angiogenesis: a role for Wnt signaling |
| Q38211726 | Macrophages associated with tumors as potential targets and therapeutic intermediates |
| Q36838542 | Macrophages define the invasive microenvironment in breast cancer |
| Q91856351 | Macrophages in Colorectal Cancer Liver Metastases |
| Q34329242 | Macrophages in multiple myeloma: emerging concepts and therapeutic implications |
| Q52351121 | Macrophages in skin melanoma-the key element in melanomagenesis. |
| Q34824357 | Macrophages in the embryo and beyond: much more than just giant phagocytes. |
| Q36926833 | Manipulating the NF-κB pathway in macrophages using mannosylated, siRNA-delivering nanoparticles can induce immunostimulatory and tumor cytotoxic functions |
| Q27003907 | Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues |
| Q38237985 | Metastasis review: from bench to bedside |
| Q38155883 | Metronomic chemotherapy and anti-angiogenesis: can upgraded pre-clinical assays improve clinical trials aimed at controlling tumor growth? |
| Q35032481 | MicroRNA-17, 20a regulates the proangiogenic function of tumor-associated macrophages via targeting hypoxia-inducible factor 2α |
| Q39065988 | Microvesicle-delivery miR-150 promotes tumorigenesis by up-regulating VEGF, and the neutralization of miR-150 attenuate tumor development |
| Q21245767 | Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells |
| Q60924965 | Modulation of double-stranded RNA pattern recognition receptor signaling in ovarian cancer cells promotes inflammatory queues |
| Q37027092 | Monocyte Differentiation towards Protumor Activity Does Not Correlate with M1 or M2 Phenotypes |
| Q37028772 | Monocytes and macrophages in cancer: development and functions |
| Q64280844 | Mouse Models as a Tool for Understanding Progression in Braf-Driven Thyroid Cancers |
| Q34063800 | Myeloid WNT7b mediates the angiogenic switch and metastasis in breast cancer |
| Q37866991 | Myeloid cells in cancer progression: unique subtypes and their roles in tumor growth, vascularity, and host immune suppression |
| Q36168410 | Notch Signaling in Inflammation-Induced Preterm Labor |
| Q35257755 | Novel stromal biomarkers in human breast cancer tissues provide evidence for the more malignant phenotype of estrogen receptor-negative tumors |
| Q36230712 | Nuclear expression of N-myc downstream regulated gene 1/Ca(2+)-associated protein 43 is closely correlated with tumor angiogenesis and poor survival in patients with gastric cancer |
| Q38649483 | Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention. |
| Q39011826 | One microenvironment does not fit all: heterogeneity beyond cancer cells |
| Q38114060 | Particle platforms for cancer immunotherapy |
| Q47437633 | Phagocyte-extracellular matrix crosstalk empowers tumor development and dissemination |
| Q36305520 | Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumors |
| Q92181818 | Potentials of C-C motif chemokine 2-C-C chemokine receptor type 2 blockers including propagermanium as anticancer agents |
| Q37306894 | Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268. |
| Q35667318 | Prevention of Bone Metastases in Breast Cancer Patients. Therapeutic Perspectives |
| Q28550556 | Prodrug AST-003 Improves the Therapeutic Index of the Multi-Targeted Tyrosine Kinase Inhibitor Sunitinib |
| Q38813025 | Progress towards understanding heterotypic interactions in multi-culture models of breast cancer |
| Q33688940 | Prostate cancer-derived CCN3 induces M2 macrophage infiltration and contributes to angiogenesis in prostate cancer microenvironment |
| Q34457327 | RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment |
| Q36629504 | RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration. |
| Q49887925 | Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges |
| Q90452421 | Reduced Protumorigenic Tumor-Associated Macrophages With Statin Use in Premalignant Human Lung Adenocarcinoma |
| Q35546629 | Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells |
| Q33748699 | Retracted: Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Prostate Cancer Cell Migration and Invasion Induced by Tumor-Associated Macrophages |
| Q33707131 | Retracted: Macrophage Colony-Stimulating Factor Augments Tie2-Expressing Monocyte Differentiation, Angiogenic Function, and Recruitment in a Mouse Model of Breast Cancer |
| Q36284948 | Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes |
| Q37393413 | Role of hepatic resident and infiltrating macrophages in liver repair after acute injury. |
| Q35948515 | Role of reactive oxygen and nitrogen species in the vascular responses to inflammation |
| Q91649066 | Roles of cell fusion, hybridization and polyploid cell formation in cancer metastasis |
| Q24598566 | S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways |
| Q91967500 | Sex differences in cancer mechanisms |
| Q41815223 | Similar lymphocytic infiltration pattern in primary breast cancer and their corresponding distant metastases |
| Q95270102 | Spatial immune profiling of the colorectal tumor microenvironment predicts good outcome in stage II patients |
| Q37170570 | Specific inhibition of PI3K p110δ inhibits CSF-1-induced macrophage spreading and invasive capacity |
| Q38125197 | Strategies to increase drug penetration in solid tumors |
| Q50744551 | Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma. |
| Q47096116 | TAMeless traitors: macrophages in cancer progression and metastasis |
| Q36710907 | TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancer |
| Q58547311 | Targeting macrophages: therapeutic approaches in cancer |
| Q26765184 | Targeting the CCL2-CCR2 signaling axis in cancer metastasis |
| Q37359115 | Targeting tumor angiogenesis with histone deacetylase inhibitors |
| Q39188002 | The Dr. Jekyll and Mr. Hyde complexity of the macrophage response in disease |
| Q41284044 | The Expression and Relationship of CD68-Tumor-Associated Macrophages and Microvascular Density With the Prognosis of Patients With Laryngeal Squamous Cell Carcinoma |
| Q49593660 | The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets |
| Q57816901 | The Role of the Extracellular Matrix and Its Molecular and Cellular Regulators in Cancer Cell Plasticity |
| Q91963436 | The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis |
| Q36491653 | The anti-tumour effects of zoledronic acid |
| Q34443090 | The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion |
| Q92644598 | The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor |
| Q36499781 | The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer |
| Q37074568 | The effect of thrombospondin-1 on breast cancer metastasis |
| Q33860043 | The expression of heparin-binding epidermal growth factor-like growth factor by regulatory macrophages |
| Q37118197 | The flip side of immune surveillance: immune dependency |
| Q37033451 | The immune system and inflammation in breast cancer |
| Q36928869 | The metastatic niche: adapting the foreign soil |
| Q38102568 | The molecular and cell biology of pediatric low-grade gliomas. |
| Q47813995 | The nuclear factor-kappa B pathway and response to treatment in breast cancer |
| Q90283435 | The phenotypic and functional properties of mouse yolk-sac-derived embryonic macrophages |
| Q53151983 | The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma. |
| Q36935954 | The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer |
| Q37243959 | The relevance of mouse models to understanding the development and progression of human breast cancer |
| Q34546566 | The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression |
| Q37554682 | The role of tumor-associated macrophages in tumor vascularization |
| Q41682512 | Therapeutic potential of GW501516 and the role of Peroxisome proliferator-activated receptor β/δ and B-cell lymphoma 6 in inflammatory signaling in human pancreatic cancer cells |
| Q30496577 | Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction |
| Q37209024 | Toward a stem cell gene therapy for breast cancer |
| Q36829147 | Trophic macrophages in development and disease |
| Q49544289 | Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer |
| Q29614938 | Tumor angiogenesis |
| Q37346644 | Tumor macrophages are pivotal constructors of tumor collagenous matrix. |
| Q37984168 | Tumor microenvironment and breast cancer progression: a complex scenario |
| Q26774355 | Tumor resistance to vascular disrupting agents: mechanisms, imaging, and solutions |
| Q39205186 | Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation |
| Q37822464 | Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics |
| Q54967714 | Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant chemotherapy. |
| Q35906771 | Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated |
| Q91835845 | Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications |
| Q39367300 | Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer |
| Q38230880 | Tumor-associated macrophages: from mechanisms to therapy |
| Q39148281 | Tumor-associated macrophages: implications in cancer immunotherapy |
| Q37309171 | Tumor-host interactions: the role of inflammation |
| Q90578148 | Tumour-associated macrophages mediate the invasion and metastasis of bladder cancer cells through CXCL8 |
| Q27004702 | Understanding dendritic cells and their role in cutaneous carcinoma and cancer immunotherapy |
| Q38788965 | Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1α/VEGF signals |
| Q36676685 | Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages |
| Q35944176 | Vorinostat-An Overview |
| Q89621107 | YKL-39 as a Potential New Target for Anti-Angiogenic Therapy in Cancer |
| Q36703854 | cMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer |
| Q30365899 | uPAR induces expression of transforming growth factor β and interleukin-4 in cancer cells to promote tumor-permissive conditioning of macrophages. |
| Q38170360 | β1 integrin: Critical path to antiangiogenic therapy resistance and beyond |
Search more.